• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume10, Issue4

TO ASSESS OCULAR BIOMETRIC AND FUNDOSCOPIC CHANGES IN BETA-THALASSEMIA MAJOR PATIENT

    Dr Saptarshi Mondal, Dr Malabika Debbarma Dr. Pekila Lama Bhutia Dr. Gangotri Barui, Prof. Dr. Mukul Chandra Biswas

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 4, Pages 759-766

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Thalassemia are the most common single gene disorder worldwide. Mutations involving the beta globin gene in beta-thalassemia cause disruption in red blood cell maturation leading to ineffective erythropoiesis and multi-system involvement, including eye. In beta-thalassemia patient abnormal erythropoiesis leads to severe anemia, due to which repeated blood transfusions are required to maintain hemoglobin level at or above 10mg/dl. Multiple blood transfusions and ineffective erythropoiesis.
Aims:  To study the prevalence of ocular abnormalities in beta thalassemia major patients.
Materials and Methods: The present study was a Institution based descriptive, cross-sectional study. This Study was conducted from one and half year (February 2020 -August 2021) at Department of Ophthalmology North Bengal Medical College and Hospital.
Result: The present study showed that among 75 study subjects 93.3% had refractive errors in either eye and 6.7 % were emmetropic. The present study also showed that among 150 eyes 6% eyes had emmetropia, 69.66% had hypermetropia, 38.66 % eyes had myopia and 45.33% eyes had astigmatism. The mean axial length in our study was 21.78 + 0.73 mm, The mean anterior chamber depth (ACD) in our study was 3.00 + 0.48 mm, The mean (SD) lens thickness in right eye was 4.05 (±0.58) mm and in left eye were 3.90 ((±0.68) mm. In our study the mean (SD) K1 in right eye was 44.61 (±1.49) Diopter and in left eye were 44.87 ((±1.68) Diopter, whereas the mean (SD) K2 in right eye was 44.84 (±1.62) Diopter and in left eye were 45.07 ((±1.43) Diopter.
Conclusion: We included 75 patients of Beta Thalassemia Major patients. The male population was 56% and female were 44%. The mean age of the study subjects was 9.53 + 3.36 years (range 6 to 18 years).
Keywords:
    Beta thalassemia Ocular Biometric and Fundoscopic Changes
  • PDF (301 K)
  • XML
(2023). TO ASSESS OCULAR BIOMETRIC AND FUNDOSCOPIC CHANGES IN BETA-THALASSEMIA MAJOR PATIENT. European Journal of Molecular & Clinical Medicine, 10(4), 759-766.
Dr Saptarshi Mondal, Dr Malabika Debbarma Dr. Pekila Lama Bhutia Dr. Gangotri Barui, Prof. Dr. Mukul Chandra Biswas. "TO ASSESS OCULAR BIOMETRIC AND FUNDOSCOPIC CHANGES IN BETA-THALASSEMIA MAJOR PATIENT". European Journal of Molecular & Clinical Medicine, 10, 4, 2023, 759-766.
(2023). 'TO ASSESS OCULAR BIOMETRIC AND FUNDOSCOPIC CHANGES IN BETA-THALASSEMIA MAJOR PATIENT', European Journal of Molecular & Clinical Medicine, 10(4), pp. 759-766.
TO ASSESS OCULAR BIOMETRIC AND FUNDOSCOPIC CHANGES IN BETA-THALASSEMIA MAJOR PATIENT. European Journal of Molecular & Clinical Medicine, 2023; 10(4): 759-766.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 15
  • PDF Download: 25
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus